✦ LIBER ✦

The inflammasome pathway as a target of berberine in experimental steatohepatitis and acetaminophen toxicity

✍ Scribed by Vivoli, E.; Milani, S.; Provenzano, A.; Cappon, A.; Novo, E.; Parola, M.; Marra, F.

Book ID: 123135549
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 44 KB
Volume: 46
Category: Article
ISSN: 1590-8658
DOI: 10.1016/j.dld.2014.01.154

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1267 BERBERINE ADMINISTRATION AMELIORATE

1267 BERBERINE ADMINISTRATION AMELIORATES NECROINFLAMMATION IN EXPERIMENTAL STEATOHEPATITIS INTERFERING WITH THE INFLAMMASOME PATHWAY, BUT IS ASSOCIATED WITH EXTRAHEPATIC TOXICITY

✍ Vivoli, E.; Milani, S.; Provenzano, A.; Madiai, S.; Novo, E.; Parola, M.; Marra, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 72 KB

O4 BERBERINE ADMINISTRATION AMELIORATES

O4 BERBERINE ADMINISTRATION AMELIORATES EXPERIMENTAL STEATOHEPATITIS INTERFERING WITH THE INFLAMMASOME PATHWAY AND TLR-4 EXPRESSION

✍ Vivoli, E.; Milani, S.; Provenzano, A.; Madiai, S.; Novo, E.; Oliveira, C.P.M.S. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 43 KB

86 Pathway signatures of biphasic and ep

86 Pathway signatures of biphasic and epithelial mesothelioma identify the ubiquitin-proteasome pathway as a therapeutic target in poor prognosis tumors

✍ Borczuk, A.C.; Cappellini, G.C.A.; Hesdorffer, M.; Taub, R.N.; Powell, C.A. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Quantitative assessment of the glyoxalas

Quantitative assessment of the glyoxalase pathway in Leishmania infantum as a therapeutic target by modelling and computer simulation

✍ Marta Sousa Silva; António E. N. Ferreira; Ana Maria Tomás; Carlos Cordeiro; Ana 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 492 KB

Mitochondria as the target for mildronat

Mitochondria as the target for mildronate's protective effects in azidothymidine (AZT)-induced toxicity of isolated rat liver mitochondria

✍ Jolanta Pupure; Maria A. S. Fernandes; Maria S. Santos; António J. M. Moreno; Iv 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 2 views

## Abstract Previously mildronate, an aza‐butyrobetaine derivative, was shown to be a cytoprotective drug, through its mechanism of action of inhibition of carnitine palmitoyltransferase‐1, thus protecting mitochondria from long‐chain fatty acid accumulation and subsequent damage. Recently in an az

Approaches and limitations of phosphatid

Approaches and limitations of phosphatidylinositol-3-kinase pathway activation status as a predictive biomarker in the clinical development of targeted therapy

✍ Christina M. Coughlin; Daniel S. Johnston; Andrew Strahs; Michael E. Burczynski; 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 607 KB